A spironolactone derivative and selective ALDOSTERONE RECEPTOR antagonist that is used in the management of HYPERTENSION and CONGESTIVE HEART FAILURE, post-MYOCARDIAL INFARCTION.
Eplerenone has been studied across 17 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic, 😴 Sleep, 👁️ Vision & Eye. The primary research focus is ❤️ Cardiovascular with 59% of studies addressing this area.
The following compounds share molecular targets with Eplerenone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Eplerenone is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.